Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary resection for multi-drug resistant tuberculosis.

B J Pomerantz1, J C Cleveland, H K Olson

  • 1Department of Surgery and the Section of Thoracic Surgery, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.

The Journal of Thoracic and Cardiovascular Surgery
|March 10, 2001
PubMed
Summary

Surgery for multi-drug resistant tuberculosis (MDR-TB) is effective. Pulmonary resection can eradicate infection in patients with localized disease or intolerance to medical therapy, with acceptable outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The future direction of the adult heart allocation system in the United States.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Organ preconditioning.

Archives of surgery (Chicago, Ill. : 1960)·2001
Same author

Off-pump coronary artery bypass grafting decreases risk-adjusted mortality and morbidity.

The Annals of thoracic surgery·2001
Same author

A decade's experience with quality improvement in cardiac surgery using the Veterans Affairs and Society of Thoracic Surgeons national databases.

Annals of surgery·2001
Same author

Off-pump coronary artery bypass is associated with improved risk-adjusted outcomes.

The Annals of thoracic surgery·2001
Same author

Clinical applications of ischemic preconditioning: from head to toe.

Surgery·2001

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Surgical Oncology

Background:

  • Mycobacterium tuberculosis remains a global health threat, with emerging multi-drug resistant tuberculosis (MDR-TB) strains posing significant challenges.
  • Complacency has contributed to the rise of highly resistant strains, increasing the risk of a worldwide epidemic.
  • Optimal treatment for MDR-TB often necessitates surgical intervention for infection eradication.

Purpose of the Study:

  • To evaluate the efficacy and safety of pulmonary resection as a treatment for multi-drug resistant tuberculosis.
  • To analyze outcomes, including morbidity and mortality, associated with surgical intervention in MDR-TB patients.

Main Methods:

  • A retrospective analysis of 172 patients who underwent 180 pulmonary resections over a 17-year period.

Related Experiment Videos

  • All patients had confirmed multi-drug resistant tuberculosis and received at least 3 months of medical therapy prior to surgery.
  • Surgical techniques included lobectomies and pneumonectomies, with frequent use of muscle flaps to manage residual spaces and bronchial stumps.

    • Main Results:

    • 98 lobectomies and 82 pneumonectomies were performed; 8 patients had multiple procedures.
    • Operative mortality was 3.3% (6/180), with causes including respiratory failure, cerebrovascular accidents, and myocardial infarction.
    • Post-operative sputum conversion was achieved in 98% of patients (4/2), with a mean follow-up of 7.6 years and late mortality of 6.8%.

    Conclusions:

    • Pulmonary resection is a vital adjunct to medical therapy for managing multi-drug resistant tuberculosis.
    • Surgery is indicated for localized disease, persistent sputum positivity, or medical therapy intolerance in MDR-TB patients.
    • Surgical treatment for MDR-TB can be performed with acceptable operative morbidity and mortality rates.